NVO Jun 2024 97.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

29.05

0.00

(0.00%)

As of 10:10AM EDT. Market open.

Loading interactive chart…

Zacks
Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
Viking Therapeutics' (VKTX) lead candidate for obesity, VK2735, is expected to have tremendous potential. However, existing competition from obesity drugs in the market remains a woe.
Investor's Business Daily
Is Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Eli Lilly stock broke out and then retreated into sell-zone territory. With shares on the rise again, is LLY stock a buy?
Zacks
Here's Why Novo Nordisk (NVO) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.